Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 4

Evaluation of Thiol/Disulfide Homeostasis in Lung Cancer

Pages
255–260
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, the thiol levels were lower in patients than the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Lung cancer is one of the most common causes of mortality all around the world.
📊
Key Findings & Data:The increased production of reactive oxygen species occurs with cell damage, and cysteine is an important factor in preventing oxidative damage by its functional thiol group.
💡
Conclusion & Impact:Overall, the thiol levels were lower in patients than the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES: Lung cancer is one of the most common causes of mortality all around the world. The increased production of reactive oxygen species occurs with cell damage, and cysteine is an important factor in preventing oxidative damage by its functional thiol group. The objective of this study was to evaluate the relationship between thiol/disulfide homeostasis (TDH) and the risk factors, disease severity, and physical condition of patients with lung cancer.MATERIALS AND METHODS: This is a prospective, controlled, nonblinded study, which included healthy volunteers and patients diagnosed with lung cancer who had not yet started any treatment.RESULTS: There were 45 male (90%) and five female (5%) patients (mean age 64±9 years), and 41 male (82%) and nine female (18%) healthy volunteers (mean age 65±17 years) were included in this research. Overall, the thiol levels were lower in patients than the control group (p

🔖

Cite This Article

ERDOĞAN, Y., EREL, Ö., ŞENER, M. U., SÖNMEZ, Ö., KEYF, İ. A., ALIŞIK, M., BULUT, S. (2022). Evaluation of Thiol/Disulfide Homeostasis in Lung Cancer. Turkish Thoracic Journal, Cilt: 21 - Sayı: 4, 255–260. https://ajindex.com/articles/618103

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. I H, Cho JY. Lung cancer biomarkers. L Adv Clin Chem 2015;72:107-70. [CrossRef] 2. Nogueira V, Hay N. Molecular pathways: Reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res 2013;19:4309-14. [CrossRef] 3. Erel Ö, Neşelioğlu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326-32. [CrossRef] 4. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. [CrossRef] 5. Dirican N, Dirican A, Sen O, et al. Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer? Redox Rep 2016;21:197-203. [CrossRef] 6. Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: Proposals for the revision of the TNM stage groupings in the forthcoming (Seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-14. [CrossRef] 7. Katsoulis K, Kontakiotis T, Papakosta D, et al. Comparison of Serum Total Antioxidant Status Between Patients with Community Acquired Pneumonia and Severe Asthma Exacerbation. HOSPITAL CHRONICLES 2010;5:1-6. 8. Esme H, Cemek M, Sezer M, et al. High levels of oxidative stress in patients with advanced lung cancer. Respirology 2008;13:112-6. [CrossRef] 9. Chan HP, Tran V, Lewis C, et al. Elevated levels of oxidative stress markers in exhaled breath condensate. J Thorac Oncol 2009;4:172-8. [CrossRef] 10. De Bona KS, Bellé LP, Bittencourt PE, et al. Erythrocytic enzymes and antioxidant status in people with type 2 diabetes: Beneficial effect of Syzygium cumini leaf extract in vitro. Diabetes Res Clin Pract 2011;94:84-90. [CrossRef] 11. Gupta A, Srivastava S, Prasad R, et al. Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response. Respirology 2010;15:349-56. [CrossRef] 12. Sotgia F, Martinez-Outschoorn UE, Lisanti MP. Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention? BMC Med 2011;9:62. doi: 10.1186/1741-7015-9-62. [CrossRef] 13. Feng JF, Lu L, Zeng P, et al. Serum total oxidant/antioxidant status and trace element levels in breast cancer patients. Int J Clin Oncol 2012;17:575-83. [CrossRef] 14. Gill JG, Piskounova E, Morrison SJ. Cancer, oxidative stress, and metastasis. Cold Spring Harb Symp Quant Biol 2016;81